Mark Cuban's online pharmacy, Cost Plus Drugs, aims to provide patients with medicine that is less expensive than traditional pharmacies.

Members of the Purchaser Business Group on Health will be able to fold the medicines sold by Mark Cuban's company into existing health benefit plans.

The J&J lawsuit should serve as a wake-up call for employers deciding who will manage their health benefits: There's an urgent need to shift their approach in PBM evaluation and selection.

The prescriptions with the most eye-popping price tags — like cancer meds that can cost more than $20,000 a month — are usually classified as "specialty" drugs. 

The supply chain that brings pharmaceutical drugs from the factory to the pharmacy is long, complex and unclear. Congress and several state legislatures have proposed or enacted laws to bring more...

Lower-cost options are starting to put pressure on middlemen who profit from an opaque business model.

Kentucky legislature's end to pharmacy benefit managers has saved Medicaid more than $200 million that's being plowed back into expanded care.

A small but growing number of "cash" pharmacies take no insurance, instead selling generic drugs, often at far lower prices than customers pay with insurance.

The billionaire’s company, Cost Plus Drug Company, has historically only sold generics.

“They keep stretching us thinner and thinner,” one of the pharmacists told The Star.

At least eight CVS pharmacies in Ohio are so understaffed that they have seen rampant turnover, dirty conditions, lack of controls over dangerous drugs and wait times for prescriptions as long as a...

People with diabetes, asthma, and other conditions often pay higher prescription costs that effectively subsidize healthier plan enrollees, researchers say 

The chair of the Federal Trade Commission said Monday that PBM drug middlemen haven't fully cooperated with the FTC's antitrust probe: "FTC orders are not suggestions and we will not hesitate to use...

Gov. Ron DeSantis announced he would be signing an executive order aimed at making prescription drugs cheaper and providing more transparency to the industry.

Bayer is adding two of its name-brand drugs to the roster of Cost Plus Drugs: the birth control pill Yaz and the menopause treatment Climara.

Rising prescription drug costs presents a unique challenge for many Americans. But while we have spent considerable public-facing time providing research and data analytics insights on the flow of...

Drug pricing experts said CVS’ new program appears designed to pad CVS’ own bottom line rather than making drugs cheaper for patients.

‘Heat wave’ for pharmacy benefit managers as lawmakers, regulators scrutinize impact on drug prices 

PBMs are under the microscope for allegedly inflating drug prices. New Barron’s reporting raises broader questions about the industry—and its role in the opioid crisis.

Don’t be fooled by recent advertisements.

Mark Cuban, owner of the Dallas Mavericks, is getting into a business pioneered by independent pharmacists in Ohio and elsewhere.

The Senate Finance Committee on Wednesday advanced a series of bipartisan proposals to tackle some of the problems with the entities that manage prescription drug coverage, as lawmakers face an...

CVS Health and other massive corporations often use their pharmacy middleman subsidiaries to force people to get the most expensive class of drugs from the businesses' own mail-order pharmacies. Some...

Small drugstore owners here in the Hudson Valley say they are having a hard time staying...

Tyson Foods drops CVS for startup PBM offering drug price transparency

State officials say the pharmacy benefit manager company has misled employers and customers about Oklahoma law.

COLUMBUS — Reacting to the high cost of life-saving EpiPens, Gov. John Kasich on Monday signed into law a bill authorizing pharmacists to substitute ...

Drug transactions are controlled by middlemen who are owned by huge health conglomerates that also own big insurers. And a new report says that those companies often list hundreds of different prices...

Legislation, Litigation, and/or Competition About a month ago, U.S. Congressman Jake Auchincloss posted on LinkedIn a potential Venn diagram of actions that may reform pharmacy benefit manager (PBM)...

The House passed a relatively major health care package late Monday, an end-of-year victory after a hiccup in September.

With states cracking down on pharmacy benefit managers' pricing, these giant corporations inserted clawbacks, or "post-transaction fees," into contracts involving local pharmacies to ensure PBMs made...

One patient's example of how new partnerships between several PBMs and GoodRx are harming pharmacies.

The plan is much lighter on proposals vis a vis pharmacy benefit managers — middlemen who handle the transactions and are known as PBMs. That marketplace is dominated by three corporations that are...

As part of its ongoing inquiry into pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the Federal Trade Commission has issu

“This particular egregiously charged for services it didn’t deliver,” Ohio Attorney General Dave Yost said in a statement. “Its repeated breaches cost Ohioans millions, and we want our money back.”

Taxpayers and state employees could be paying too much for medications. Experts say a 16-page audit commissioned by Kansas doesn't dig in to find out.